Gland Pharma Limited announced multiple changes to its board of directors following a meeting held on June 15, 2026. The board approved several resolutions covering appointments, reappointments, and committee realignments.
Udo Jahannes Vetter was reappointed as an Independent Director for a second term of five consecutive years, effective July 21, 2026 through July 20, 2031. Vetter had served on the board since July 21, 2021. He earned his degree in Clinical Pharmacy from the University of Washington and worked as a Manufacturing Pharmacist at Schering-Plough Corp. Vetter has also served as Managing Director of Vetter Pharma and Vetter Inject GmbH & Co. KG, and currently serves as Chairman of the ITM Group in Germany. He founded UV-Cap, an investment company focused on the life sciences sector, in 2004 and continues to serve as its Managing Director.
William Robert Keller was appointed as an Additional Director (Non-Executive Independent Director) effective June 15, 2026. Keller is an Independent Director at Wuxi Biologics Limited and Hua Medicine.
Satyanarayana Murthy Chavali resigned as an Independent Director due to a potential conflict of interest. A company where Chavali is a promoter and director plans to enter a business segment that may overlap with business activities Gland Pharma is contemplating entering. The resignation took effect from the close of business hours on June 15, 2026. Chavali had been associated with Gland Pharma since November 20, 2018.
Essaji Goolam Vahanvati was appointed as a Director on the board of Gland Pharma International Pte. Ltd, the company's material subsidiary, effective June 15, 2026. The board committees were realigned effective June 15, 2026 in compliance with listing regulations.
Disclaimer: This article is based on company filings submitted to the Bombay Stock Exchange (BSE) and National Stock Exchange of India (NSE) and is for informational purposes only. It does not constitute investment advice or a recommendation. Investors should conduct their own research and consult a qualified financial advisor before making investment decisions.